Roby Joyce is Director of bioAffinity Technologies, Inc.. Currently has a direct ownership of 66,615 shares of BIAF, which is worth approximately $81,936. The most recent transaction as insider was on Jul 01, 2024, when has been sold 33,784 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 66.6K
0% 3M change
461.35% 12M change
Total Value Held $81,936

Roby Joyce Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 01 2024
BUY
Grant, award, or other acquisition
-
33,784 Added 33.65%
66,615 Common Stock
Jun 12 2024
BUY
Grant, award, or other acquisition
-
8,296 Added 20.17%
32,831 Common Stock
Jan 01 2024
BUY
Grant, award, or other acquisition
$18,748 $1.48 p/Share
12,668 Added 34.05%
24,535 Common Stock
Oct 01 2023
BUY
Grant, award, or other acquisition
$18,749 $1.58 p/Share
11,867 Added 50.0%
11,867 Common Stock
RJ

Roby Joyce

Director
San Antonio,, TX

Track Institutional and Insider Activities on BIAF

Follow bioAffinity Technologies, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BIAF shares.

Notify only if

Insider Trading

Get notified when an Bio Affinity Technologies, Inc. insider buys or sells BIAF shares.

Notify only if

News

Receive news related to bioAffinity Technologies, Inc.

Track Activities on BIAF